Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis

Table 1 Basic clinical data

Clinical factor	Hepatitis cirrhosis (n = 71)	Alcoholic cirrhosis (n = 67)	Autoimmune cirrhosis (n = 62)	Statistic	P value
Gender (n)				χ2 = 3.43	0.18
Male	46	42	31
Female	25	25	31
Age (yr, mean ± SD)	55.5 ± 8.7	54.7 ± 8.5	55.3 ± 9.6	F = 0.15	0.87
Child-Pugh Classification				χ2 = 3.19	0.53
A	32	25	19
B	34	35	37
C	5	7	6
Child-Pugh score	7.25 ± 1.54	7.55 ± 1.45	7.48 ± 1.29	F = 0.82	0.44
MELD score	10.24 ± 3.52	9.67 ± 2.90	10.47 ± 2.97	F = 1.11	0.33
Prothrombin time (s)	14.59 ± 2.79	14.98 ± 2.46	14.74 ± 2.92	F = 0.36	0.69
ALT (IU/L)	35.28 ± 16.40	37.75 ± 12.17	36.95 ± 10.82	F = 0.42	0.67
AST (IU/L)	48.87 ± 24.43	50.13 ± 23.10	50. 75 ± 24.34	F = 0.06	0.94
Albumin (g/L)	35.09 ± 6.33	34.14 ± 4.52	34.23 ± 4.44	F = 0.69	0.50
Total bilirubin (μmol/L)	33.53 ± 12.99	32.75 ± 14.88	32.47 ± 16.84	F = 0.04	0.96
PPG before TIPS (mmHg)	24.58 ± 4.79	25.45 ± 5.16	25.27 ± 5.65	F = 1.78	0.17
PPG after TIPS (mmHg)	9.94 ± 2.55	10.22 ± 3.07	10.01 ± 2.65	F = 0.22	0.80
Deaths in 24 mo, n (%)	8 (11.3)	12 (17.9)	9 (14.5)	χ2 = 1.23	0.54
HE in 24 mo, n (%)	15 (21.1)	17 (25.4)	18 (29.0)	χ2 = 1.11	0.57

MELD: Model for end-stage liver disease; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TIPS: Transjugular intrahepatic portosystemic shunt; PPG: Portal pressure gradient; HE: Hepatic encephalopathy.